Novel therapeutic targets in osteoarthritis: Narrative review on knock-out genes involved in disease development in mouse animal models

Cytotherapy

Volumn 18, Issue 5, 2016, Pages 593-612

  Veronesi, Francesca ^a   Della Bella, Elena ^a,b   Cepollaro, Simona ^a,b   Brogini, Silvia ^a   Martini, Lucia ^a   Fini, Milena ^a  

^a RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Genes; Knee; Knock out; Mice; Osteoarthritis; Therapy

Indexed keywords

CARTILAGE CELL; CARTILAGE MATRIX; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; EXTRACELLULAR MATRIX; GENE EXPRESSION; GENE FUNCTION; GENOTYPE PHENOTYPE CORRELATION; HOMEOSTASIS; HUMAN; INFLAMMATION; KNOCKOUT GENE; KNOCKOUT MOUSE; MOUSE MODEL; NONHUMAN; OBESITY; OSTEOARTHRITIS; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; CHONDROCYTE; COMPLICATION; DISEASE MODEL; GENETICS; IMMUNOLOGY; MALE; METABOLISM; MOUSE; OSTEOARTHRITIS, KNEE;

ANIMALS; CHONDROCYTES; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; EXTRACELLULAR MATRIX; INFLAMMATION; MALE; MICE; MICE, KNOCKOUT; OBESITY; OSTEOARTHRITIS, KNEE;

EID: 84962106558     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.1016/j.jcyt.2016.02.001     Document Type: Review

References (88)

1. Plaas A., Osborn B., Yoshihara Y., Bai Y., Bloom T., Nelson F., et al. Aggrecanolysis in human osteoarthritis: confocal localization and biochemical characterization of ADAMTS5-hyaluronan complexes in articular cartilages. Osteoarthritis Cartilage 2007, 15:719-734.
2. Little C.B., Barai A., Burkhardt D., Smith S.M., Fosang A.J., Werb Z., et al. Matrix metalloproteinase 13-deficient mice are resistant to osteoarthritic cartilage erosion but not chondrocyte hypertrophy or osteophyte development. Arthritis Rheum 2009, 60:3723-3733.
3. Gao Y., Liu S., Huang J., Guo W., Chen J., Zhang L., et al. The ECM-cell interaction of cartilage extracellular matrix on chondrocytes. Biomed Res Int 2014, 2014:648459.
4. Goldring M.B., Goldring S.R. Osteoarthritis. J Cell Physiol 2007, 213:626-634.
5. Veronesi F., Torricelli P., Giavaresi G., Sartori M., Cavani F., Setti S., et al. In vivo effect of two different pulsed electromagnetic field frequencies on osteoarthritis. J Orthop Res 2014, 32:677-685.
6. Kozawa E., Nishida Y., Cheng X.W., Urakawa H., Arai E., Futamura N., et al. Osteoarthritic change is delayed in a ctsk-knockout mouse model of osteoarthritis. Arthritis Rheum 2012, 64:454-464.
7. Malfait A.M., Ritchie J., Gil A.S., Austin J.S., Hartke J., Qin W., et al. ADAMTS-5 deficient mice do not develop mechanical allodynia associated with osteoarthritis following medial meniscal destabilization. Osteoarthritis Cartilage 2010, 18:572-580.
8. Loeser R.F., Goldring S.R., Scanzello C.R., Goldring M.B. Osteoarthritis: a disease of the joint as an organ. Arthritis Rheum 2012, 64:1697-1707.
9. Lin C.A., Seeto B.L., Bartoszko J.M., Khoury M.A., Whetstone H., Ho L., et al. Modulating hedgehog signaling can attenuate the severity of osteoarthritis. Nat Med 2009, 15:1421-1425.
10. Liu-Bryan R., Terkeltaub R. Emerging regulators of the inflammatory process in osteoarthritis. Nat Rev Rheumatol 2015, 11:35-44.
11. Ali S.A., Al-Jazrawe M., Ma H., Whetstone H., Poon R., Farr S., et al. Regulation of cholesterol homeostasis by hedgehog signaling in osteoarthritic cartilage. Arthritis Rheum 2016, 68:127-137.
12. Bomer N., Cornelis F.M., Ramos Y.F., den Hollander W., Storms L., van der Breggen R., et al. The effect of forced exercise on knee joints in Dio2-/- mice: type II iodothyronine deiodinase-deficient mice are less prone to develop OA-like cartilage damage upon excessive mechanical stress. Ann Rheum Dis 2014.
13. Bierma-Zeinstra S.M., Koes B.W. Risk factors and prognostic factors of hip and knee osteoarthritis. Nat Clin Pract Rheumatol 2007, 3:78-85.
14. Migliore A., Procopio S. Effectiveness and utility of hyaluronic acid in osteoarthritis. Clin Cases Miner Bone Metab 2015, 12:31-33.
15. Henrotin Y., Lambert C., Richette P. Importance of synovitis in osteoarthritis: evidence for the use of glycosaminoglycans against synovial inflammation. Semin Arthritis Rheum 2014, 43:579-587.
16. Veronesi F., Maglio M., Tschon M., Aldini N.N., Fini M. Adipose-derived mesenchymal stem cells for cartilage tissue engineering: state-of-the-art in in vivo studies. J Biomed Mater Res A 2014, 102:2448-2466.
17. Thysen S., Luyten F.P., Lories R.J.U. Targets, models and challenges in osteoarthritis research. Dis Model Mech 2015, 8:17-30.
18. Glasson S.S., Blanchet T.J., Morris E.A. The surgical destabilization of the medial meniscus (DMM) model of osteoarthritis in the 129/SvEv mouse. Osteoarthritis Cartilage 2007, 15:1061-1069.
19. Kamekura S., Kawasaki Y., Hoshi K., Shimoaka T., Chikuda H., Maruyama Z., et al. Contribution of runt-related transcription factor 2 to the pathogenesis of osteoarthritis in mice after induction of knee joint instability. Arthritis Rheum 2006, 54:2462-2470.
20. Fang H., Beier F. Mouse models of osteoarthritis: modelling risk factors and assessing outcomes. Nat Rev Rheumatol 2014, 10:413-421.
21. Hirata M., Kugimiya F., Fukai A., Saito T., Yano F., Ikeda T., et al. C/EBPb and RUNX2 cooperate to degrade cartilage with MMP-13 as the target and HIF-2a as the inducer in chondrocytes. Hum Mol Genet 2012, 21:1111-1123.
22. Hosaka Y., Saito T., Sugita S., Hikata T., Kobayashi H., Fukai A., et al. Notch signaling in chondrocytes modulates endochondral ossification and osteoarthritis development. PNAS 2013, 110:1875-1880.
23. Uehara Y., Hirose J., Yamabe S., Okamoto N., Okada T., Oyadomari S., et al. Endoplasmic reticulum stress-induced apoptosis contributes to articular cartilage degeneration via C/EBP homologous protein. Osteoarthritis Cartilage 2014, 22:1007-1017.
24. Matsuzaki T., Matsushita T., Takayama K., Matsumoto T., Nishida K., Kuroda R., et al. Disruption of Sirt1 in chondrocytes causes accelerated progression of osteoarthritis under mechanical stress and during ageing in mice. Ann Rheum Dis 2014, 73:1397-1404.
25. Joiner D.M., Less K.D., Van Wieren E.M., Zhang Y.W., Hess D., Williams B.O. Accelerated and increased joint damage in young mice with global inactivation of mitogen-inducible gene 6 after ligament and meniscus injury. Arthritis Res Ther 2014, 16:R81.
26. Ratneswaran A., LeBlanc E.A., Walser E., Welch I., Mort J.S., Borradaile N., et al. Peroxisome proliferator-activated receptor δ promotes the progression of posttraumatic osteoarthritis in a mouse model. Arthritis Rheum 2015, 67:454-464.
27. Yang S., Kim J., Ryu J.H., Oh H., Chun C.H., Kim B.J., et al. Hypoxia-inducible factor-2α is a catabolic regulator of osteoarthritic cartilage destruction. Nat Med 2010, 16:687-694.
28. Bertrand J., Nitschke Y., Fuerst M., Hermann S., Schäfers M., Sherwood J., et al. Decreased levels of nucleotide pyrophosphatase phosphodiesterase 1 are associated with cartilage calcification in osteoarthritis and trigger osteoarthritic changes in mice. Ann Rheum Dis 2012, 71:1249-1253.
29. Jeon J., Oh H., Lee G., Ryu J.H., Rhee J., Kim J.H., et al. Cytokine-like 1 knock-out mice (Cytl1-/-) show normal cartilage and bone development but exhibit augmented osteoarthritic cartilage destruction. J Biol Chem 2011, 286:27206-27213.
30. Zhen G., Wen C., Jia X., Li Y., Crane J.L., Mears S.C., et al. Inhibition of TGF-β signaling in mesenchymal stem cells of subchondral bone attenuates osteoarthritis. Nat Med 2013, 19:704-714.
31. Shi J., Liang Q., Zuscik M., Shen J., Chen D., Xu H., et al. Distribution and alteration of lymphatic vessels in knee joints of normal and osteoarthritic mice. Arthritis Rheumatol 2014, 66:657-666.
32. Lories R.J.U., Peeters J., Bakker A., Tylzanowski P., Derese I., Schrooten J., et al. Articular cartilage and biomechanical properties of the long bones in Frzb-knockout mice. Arthritis Rheum 2007, 56:4095-4103.
33. Vasheghani F., Monemdjou R., Fahmi H., Zhang Y., Perez G., Blati M., et al. Adult cartilage-specific peroxisome proliferatore activated receptor gamma knockout mice exhibit the spontaneous osteoarthritis phenotype. Am J Pathol 2013, 182:1099-1106.
34. Gabay O., Oppenhiemer H., Meir H., Zaal K., Sanchez C., Dvir-Ginzberg M. Increased apoptotic chondrocytes in articular cartilage from adult heterozygous SirT1 mice. Ann Rheum Dis 2012, 71:613-616.
35. Taniguchi N., Caramés B., Ronfani L., Ulmer U., Komiya S., Bianchi M.E., et al. Aging-related loss of the chromatin protein HMGB2 in articular cartilage is linked to reduced cellularity and osteoarthritis. Proc Natl Acad Sci U S A 2009, 106:1181-1186.
36. Gilbert S.J., Meakin L.B., Bonnet C.S., Nowell M.A., Ladiges W.C., Morton J., et al. Deletion of P58IPK, the cellular inhibitor of the protein kinases PKR and PERK, causes bone changes and joint degeneration in mice. Front Endocrinol (Lausanne) 2014, 5:174.
37. Zhang Y.W., Su Y., Lanning N., Swiatek P.J., Bronson R.T., Sigler R., et al. Targeted disruption of Mig-6 in the mouse genome leads to early onset degenerative joint disease. PNAS 2005, 102:11740-11745.
38. Staal B., Williams B.O., Beier F., Vande Woude G.F., Zhang Y.W. Cartilage-specific deletion of Mig-6 results in osteoarthritis-like disorder with excessive articular chondrocyte proliferation. PNAS 2014, 111:2590-2595.
39. Pest M.A., Russell B.A., Zhang Y.W., Jeong J.W., Beier F. Disturbed cartilage and joint homeostasis resulting from a loss of mitogen-inducible gene 6 in a mouse model of joint dysfunction. Arthritis Rheum 2014, 66:2816-2827.
40. Shen J., Li J., Wang B., Jin H., Wang M., Zhang Y., et al. Deletion of the transforming growth factor β receptor type II gene in articular chondrocytes leads to a progressive osteoarthritis-like phenotype in mice. Arthritis Rheum 2013, 65:3107-3119.
41. Chen C.G., Thuillier D., Chin E.N., Alliston T. Chondrocyte-intrinsic Smad3 represses Runx2-inducible matrix metalloproteinase 13 expression to maintain articular cartilage and prevent osteoarthritis. Arthritis Rheum 2012, 64:3278-3289.
42. Sniekers Y.H., van Osch G.J.V.M., Ederveen A.G.H., Inzunza J., Gustafsson J.A., van Leeuwen J.P., et al. Development of osteoarthritic features in estrogen receptor knockout mice. Osteoarthritis Cartilage 2009, 17:1356-1361.
43. Roudier M., Li X., Niu Q.T., Pacheco E., Pretorius J.K., Graham K., et al. Sclerostin is expressed in articular cartilage but loss or inhibition does not affect cartilage remodeling during aging or following mechanical injury. Arthritis Rheum 2013, 65:721-731.
44. Lories R.J.U., Peeters J., Szlufcik K., Hespel P., Luyten F.P. Deletion of frizzled-related protein reduces voluntary running exercise performance in mice. Osteoarthritis Cartilage 2009, 17:390-396.
45. Botter S.M., Glasson S.S., Hopkins B., Clockaerts S., Weinans H., van Leeuwen J.P., et al. ADAMTS5-/- mice have less subchondral bone changes after induction of osteoarthritis through surgical instability: implications for a link between cartilage and subchondral bone changes. Osteoarthritis Cartilage 2009, 17:636-645.
46. Glasson S.S., Askew R., Sheppard B., Carito B., Blanchet T., Ma H.L., et al. Deletion of active ADAMTS5 prevents cartilage degradation in a murine model of osteoarthritis. Nature 2005, 434:644-648.
47. Majumdar M.K., Askew R., Schelling S., Stedman N., Blanchet T., Hopkins B., et al. Double-knockout of ADAMTS-4 and ADAMTS-5 in mice results in physiologically normal animals and prevents the progression of osteoarthritis. Arthritis Rheum 2007, 56:3670-3674.
48. Amiable N., Martel-Pelletier J., Lussier B., Kwan Tat S., Pelletier J.P., Boileau C. Proteinase-activated receptor-2 gene disruption limits the effect of osteoarthritis on cartilage in mice: a novel target in joint degradation. J Rheumatol 2014, 38:911-920.
49. Ferrell W.R., Kelso E.B., Lockhart J.C., Plevin R., McInnes I.B. Protease-activated receptor 2: a novel pathogenic pathway in a murine model of osteoarthritis. Ann Rheum Dis 2010, 69:2051-2054.
50. van Lent P.L.E.M., Blom A.B., Schelbergen R.F.P., Slöetjes A., Lafeber F.P., Lems W.F., et al. Active involvement of alarmins S100A8 and S100A9 in the regulation of synovial activation and joint destruction during mouse and human osteoarthritis. Arthritis Rheum 2012, 64:1466-1476.
51. Cecil D.L., Appleton C.T., Polewski M.D., Mort J.S., Schmidt A.M., Bendele A., et al. The pattern recognition receptor CD36 is a chondrocyte hypertrophy marker associated with suppression of catabolic responses and promotion of repair responses to inflammatory stimuli. J Immunol 2009, 182:5024-5031.
52. Nasi S., Ea H.K., Chobaz V., van Lent P., Lioté F., So A., et al. Dispensable role of myeloid differentiation primary response gene 88 (MyD88) and MyD88-dependent toll-like receptors (TLRs) in a murine model of osteoarthritis. Joint Bone Spine 2014, 81:320-324.
53. Hsieh J.L., Shiau A.L., Lee C.H., Yang S.J., Lee B.O., Jou I.M., et al. CD8+ T cell-induced expression of tissue inhibitor of metalloproteinses-1 exacerbated osteoarthritis. Int J Mol Sci 2013, 14:19951-19970.
54. Shen P.C., Wu C.L., Jou I.M., Lee C.H., Juan H.Y., Lee P.J., et al. T helper cells promote disease progression of osteoarthritis by inducing macrophage inflammatory protein-1γ. Osteoarthritis Cartilage 2011, 19:728-736.
55. Lepus C.M., Song J.J., Wang Q., Wagner C.A., Lindstrom T.M., Chu C.R., et al. Brief report: carboxypeptidase B serves as a protective mediator in osteoarthritis. Arthritis Rheumatol 2014, 66:101-106.
56. Fukai A., Kamekura S., Chikazu D., Nakagawa T., Hirata M., Saito T., et al. Lack of a chondroprotective effect of cyclooxygenase 2 inhibition in a surgically induced model of osteoarthritis in mice. Arthritis Rheum 2012, 64:198-203.
57. Blom A.B., van Lent P.L., Libregts S., Holthuysen A.E., van der Kraan P.M., van Rooijen N., et al. Crucial role of macrophages in matrix metalloproteinase-mediated cartilage destruction during experimental osteoarthritis: involvement of matrix metalloproteinase 3. Arthritis Rheum 2007, 56:147-157.
58. Böhm B.B., Aigner T., Roy B., Brodie T.A., Blobel C.P., Burkhardt H. Homeostatic effects of the metalloproteinase disintegrin ADAM15 in degenerative cartilage remodeling. Arthritis Rheum 2005, 52:1100-1109.
59. Sahebjam S., Khokha R., Mort J.S. Increased collagen and aggrecan degradation with age in the joints of Timp3(-/-) mice. Arthritis Rheum 2007, 56:905-909.
60. de Hooge A.S.K., van de Loo F.A.J., Bennink M.B., Arntz O.J., de Hooge P., van den Berg W.B., et al. 6 gene knock out mice developed more advanced osteoarthritis upon aging. Osteoarthritis Cartilage 2005, 13:66-73.
61. Ea H.K., Chobaz V., Nguyen C., Nasi S., van Lent P., Daudon M., et al. Pathogenic role of basic calcium phosphate crystals in destructive arthropathies. PloS ONE 2013, 8:e57352.
62. Christensen S.E., Coles J.M., Zelenski N.A., Furman B.D., Leddy H.A., Zauscher S., et al. Altered trabecular bone structure and delayed cartilage degeneration in the knees of collagen vi null mice. PloS ONE 2012, 7:e33397.
63. Nuka S., Zhou W., Henry S.P., Gendron C.M., Schultz J.B., Shinomura T., et al. Phenotypic characterization of epiphycan-deficient and epiphycan/biglycan double-deficient mice. Osteoarthritis Cartilage 2010, 18:88-96.
64. Hu K., Xu L., Cao L., Flahiff C.M., Brussiau J., Ho K., et al. Pathogenesis of osteoarthritis-like changes in the joints of mice deficient in type IX collagen. Arthritis Rheum 2006, 54:2891-2900.
65. Okamura N., Hasegawa M., Nakoshi Y., Iino T., Sudo A., Imanaka-Yoshida K., et al. Deficiency of tenascin-C delays articular cartilage repair in mice. Osteoarthritis Cartilage 2010, 18:839-848.
66. Matsui Y., Iwasaki N., Kon S., Takahashi D., Morimoto J., Matsui Y., et al. Accelerated development of aging-associated and instability-induced osteoarthritis in osteopontin-deficient mice. Arthritis Rheum 2009, 60:2362-2371.
67. Martin D.C., Atmuri V., Hemming R.J., Farley J., Mort J.S., Byers S., et al. A mouse model of human mucopolysaccharidosis IX exhibits osteoarthritis. Hum Mol Genet 2008, 17:1904-1915.
68. Seito N., Yamashita T., Tsukuda Y., Matsui Y., Urita A., Onodera T., et al. Interruption of glycosphingolipid synthesis enhances osteoarthritis development in mice. Arthritis Rheum 2012, 64:2579-2588.
69. Kaneko H., Ishijima M., Futami I., Tomikawa-Ichikawa N., Kosaki K., Sadatsuki R., et al. Synovial perlecan is required for osteophyte formation in knee osteoarthritis. Matrix Biol 2013, 32:178-187.
70. O'Conor C.J., Griffin T.M., Liedtke W., Guilak F. Increased susceptibility of Trpv4-deficient mice to obesity and obesity-induced osteoarthritis with very high-fat diet. Ann Rheum Dis 2013, 72:300-304.
71. Triantaphyllidou I.E., Kalyvioti E., Karavia E., Lilis I., Kypreos K.E., Papachristou D.J. Perturbations in the HDL metabolic pathway predispose to the development of osteoarthritis in mice following long-term exposure to western-type diet. Osteoarthritis Cartilage 2013, 21:322-330.
72. de Munter W., Blom A.B., Helsen M.M., Walgreen B., van der Kraan P.M., Joosten L.A., et al. Cholesterol accumulation caused by low density lipoprotein receptor deficiency or a cholesterol-rich diet results in ectopic bone formation during experimental osteoarthritis. Arthritis Res Ther 2013, 15:R178.
73. Lorenz H., Richter W. Osteoarthritis: cellular and molecular changes in degenerating cartilage. Prog Histochem Cytochem 2006, 40:135-163.
74. Borrelli J., Silva M.J., Zaegel M.A., Franz C., Sandell L.J. Single high-energy impact load causes posttraumatic OA in young rabbits via a decrease in cellular metabolism. J Orthop Res 2009, 27:347-352.
75. Wang Q., Rozelle A.L., Lepus C.M., Scanzello C.R., Song J.J., Larsen D.M., et al. Identification of a central role for complement in osteoarthritis. Nat Med 2011, 17:1674-1679.
76. Panoutsopoulou K., Southam L., Elliott K.S., Wrayner N., Zhai G., Beazley C., et al. Concise report: insights into the genetic architecture of osteoarthritis from stage 1 of the arcOGEN study. Ann Rheum Dis 2011, 70:864-867.
77. Miller R.E., Lu Y., Tortorella M.D., Malfait A.M. Genetically engineered mouse models reveal the importance of proteases as drug targets in osteoarthritis. Curr Rheumatol Rep 2013, 15:350.
78. Eltawil N.M., De Bari C., Achan P., Pitzalis C., Dell'accio F. A novel in vivo murine model of cartilage regeneration. Age and strain-dependent outcome after joint surface injury. Osteoarthritis Cartilage 2009, 17:695-704.
79. Vincent T.L., Williams R.O., Maciewicz R., Silman A., Garside P. Mapping pathogenesis of arthritis through small animal models. Rheumatology 2012, 51:1931-1941.
80. Griffin T.M., Fermor B., Huebner J.L., Kraus V.B., Rodriguiz R.M., Wetsel W.C., et al. Diet-induced obesity differentially regulates behavioral, biomechanical, and molecular risk factors for osteoarthritis in mice. Arthritis Res Ther 2010, 12:R130.
81. Zhu M., Tang D., Wu Q., Hao S., Chen M., Xie C., et al. Activation of β-catenin signaling in articular chondrocytes leads to osteoarthritis-like phenotype in adult β-catenin conditional activation mice. J Bone Miner Res 2009, 23:12-21.
82. Zhu M., Chen M., Zuscik M., Wu Q., Wang Y.J., Rosier R.N., et al. Inhibition of β-catenin signaling in articular chondrocytes results in articular cartilage destruction. Arthritis Rheum 2008, 58:2053-2064.
83. Liu Z., Chen J., Mirando A.J., Wang C., Zuscik M.J., O'Keefe R.J., et al. A dual role for NOTCH signaling in joint cartilage maintenance and osteoarthritis. Sci Signal 2015, 8:ra71.
84. Vasheghani F., Zhang Y., Li Y.H., Blati M., Fahmi H., Lussier B., et al. PPARγ deficiency results in severe, accelerated osteoarthritis associated with aberrant mTOR signalling in the articular cartilage. Ann Rheum Dis 2015, 74:569-578.
85. Zhang Y., Vasheghani F., Li Y.H., Blati M., Simeone K., Fahmi H., et al. Cartilage-specific deletion of mTOR upregulates autophagy and protects mice from osteoarthritis. Ann Rheum Dis 2015, 74:1432-1440.
86. Burr D.B. Increased biological activity of subchondral mineralized tissues underlies the progressive deterioration of articular cartilage in osteoarthritis. J Rheumatol 2005, 32:1156-1158.
87. Moon P.M., Beier F. Novel insights into osteoarthritis joint pathology from studies in mice. Curr Rheumatol Rep 2015, 17:50.
88. Glasson S.S. In vivo osteoarthritis target validation utilizing genetically-modified mice. Curr Drug Targets 2007, 8:367-376.